Buzzing :

Sapta Dhara RoadMap AI skills training Free coaching centres India Health Transformation Sebi Bond platform rules Screenless fitness tracker Independence Day travel demand Vodafone Idea Share OTT Releases This Week

Suven Life Sciences secures four product patents for their NCE's

Capital Market

Last Updated : May 24 2016 | 12:06 AM IST

Add as Preferred source

In Australia, Eurasia, Israel and USA

Suven Life Sciences announced that they secured patents in Australia, Eurasia, Israel and USA to their New Chemical Entities for CNS therapy through mechanism of action - H3 Inverse agonist and these patents are valid until 2032, 2030, 2031 and 2032 respectively.

Powered by Capital Market - Live News

Connect with us on WhatsApp